Beijing Staidson Biopharmaceuticals Co., Ltd.
Overview
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic and biological drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; chemical drugs; and drugs for urinary, intestinal, infectious, autoimmune, nervous system, and other diseases. Its product portfolio includes Mouse Nerve Growth factor for injection, Compound Polyethylene Glycol Electrolyte Powder (IV), Troponium
Employees491
Market Cap$11.7B
Revenue$203.9M
Listed OnShenzhen Stock Exchange
Ticker300204
CEOMr. Wang Chao
HeadquartersBeijing